Cargando…

Secondary and tertiary treatments for multiple sclerosis patients with urinary symptoms

Multiple sclerosis patients with refractory urinary symptoms after treatment with behavioral therapy and medications still have treatment options. Prior to starting treatments, baseline symptoms should be assessed and treatment goals thoroughly discussed. Catheterization, botulinum toxin, and recons...

Descripción completa

Detalles Bibliográficos
Autores principales: Tracey, James M., Stoffel, John T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109793/
https://www.ncbi.nlm.nih.gov/pubmed/27847911
http://dx.doi.org/10.4111/icu.2016.57.6.377
_version_ 1782467608974458880
author Tracey, James M.
Stoffel, John T.
author_facet Tracey, James M.
Stoffel, John T.
author_sort Tracey, James M.
collection PubMed
description Multiple sclerosis patients with refractory urinary symptoms after treatment with behavioral therapy and medications still have treatment options. Prior to starting treatments, baseline symptoms should be assessed and treatment goals thoroughly discussed. Catheterization, botulinum toxin, and reconstructive surgery all can play a role in improving both safety and quality of life for these patients. Newer modalities, such as neuromodulation, may also have an increasing role in the future as more data develop regarding efficacy. Risks need to be weighed against any perceived benefit and disease status before more aggressive therapy is initiated.
format Online
Article
Text
id pubmed-5109793
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher The Korean Urological Association
record_format MEDLINE/PubMed
spelling pubmed-51097932016-11-15 Secondary and tertiary treatments for multiple sclerosis patients with urinary symptoms Tracey, James M. Stoffel, John T. Investig Clin Urol Review Article Multiple sclerosis patients with refractory urinary symptoms after treatment with behavioral therapy and medications still have treatment options. Prior to starting treatments, baseline symptoms should be assessed and treatment goals thoroughly discussed. Catheterization, botulinum toxin, and reconstructive surgery all can play a role in improving both safety and quality of life for these patients. Newer modalities, such as neuromodulation, may also have an increasing role in the future as more data develop regarding efficacy. Risks need to be weighed against any perceived benefit and disease status before more aggressive therapy is initiated. The Korean Urological Association 2016-11 2016-10-24 /pmc/articles/PMC5109793/ /pubmed/27847911 http://dx.doi.org/10.4111/icu.2016.57.6.377 Text en © The Korean Urological Association, 2016 http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Tracey, James M.
Stoffel, John T.
Secondary and tertiary treatments for multiple sclerosis patients with urinary symptoms
title Secondary and tertiary treatments for multiple sclerosis patients with urinary symptoms
title_full Secondary and tertiary treatments for multiple sclerosis patients with urinary symptoms
title_fullStr Secondary and tertiary treatments for multiple sclerosis patients with urinary symptoms
title_full_unstemmed Secondary and tertiary treatments for multiple sclerosis patients with urinary symptoms
title_short Secondary and tertiary treatments for multiple sclerosis patients with urinary symptoms
title_sort secondary and tertiary treatments for multiple sclerosis patients with urinary symptoms
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109793/
https://www.ncbi.nlm.nih.gov/pubmed/27847911
http://dx.doi.org/10.4111/icu.2016.57.6.377
work_keys_str_mv AT traceyjamesm secondaryandtertiarytreatmentsformultiplesclerosispatientswithurinarysymptoms
AT stoffeljohnt secondaryandtertiarytreatmentsformultiplesclerosispatientswithurinarysymptoms